Rituximab vs Azathioprine for Maintenance of Remission in Patients With ANCA-Associated Vasculitis and Relapsing Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial
Ann. Rheum. Dis 2023 Mar 23;[EPub Ahead of Print], RM Smith, RB Jones, U Specks, S Bond, M Nodale, R Al-Jayyousi, J Andrews, A Bruchfeld, B Camilleri, S Carette, CK Cheung, V Derebail, T Doulton, A Ferraro, L Forbess, S Fujimoto, S Furuta, O Gewurz-Singer, L Harper, T Ito-Ihara, N Khalidi, R Klocke, C Koening, Y Komagata, C Langford, P Lanyon, R Luqmani, C McAlear, LW Moreland, K Mynard, P Nachman, C Pagnoux, CA Peh, C Pusey, D Ranganathan, RL Rhee, R Spiera, AG Sreih, V Tesar, G Walters, C Wroe, D Jayne, PA MerkelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.